Navigator

      Support By : Li-lab

Drugs And Genes
Negative Drug Target Genes
GENE_SYMBOL DRUG_NAME Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) Potency (nM) AC50 (nM) Datasource
ST14 H-Cys(1)-Pro-Ala-Tyr-Ser-Arg-Tyr-Leu-Asp-Cys(1)-OH 1000000 NA NA NA NA NA TTD
ST14 (3R,8R,11S,14S,17S,20S,23S,26S,29S,32S)-3-amino-29-(4-aminobutyl)-11,23-dibenzyl-20-[(1-carbamimidoylpiperidin-4-yl)methyl]-26-[3-(diaminomethylideneamino)propyl]-17-methyl-14-(2-methylpropyl)-2,10,13,16,19,22,25,28,31-nonaoxo-5,6-dithia-1,9,12,15,18,21,24,27,30-nonazabicyclo[30.3.0]pentatriacontane-8-carboxylic acid 1000000 NA NA NA NA NA TTD
ST14 (3R,8R,11S,14S,17S,20S,23S,26S,29S,32S)-3-amino-11,23-dibenzyl-20-[(1-carbamimidoylpiperidin-4-yl)methyl]-26-[3-(diaminomethylideneamino)propyl]-17,29-dimethyl-14-(2-methylpropyl)-2,10,13,16,19,22,25,28,31-nonaoxo-5,6-dithia-1,9,12,15,18,21,24,27,30-nonazabicyclo[30.3.0]pentatriacontane-8-carboxylic acid 1000000 NA NA NA NA NA TTD
ST14 (3R,8R,11S,14S,17S,20S,23S,26S,29S,32S)-3-amino-23-benzyl-20-[(1-carbamimidoylpiperidin-4-yl)methyl]-26-[3-(diaminomethylideneamino)propyl]-11-(1H-indol-3-ylmethyl)-17,29-dimethyl-14-(2-methylpropyl)-2,10,13,16,19,22,25,28,31-nonaoxo-5,6-dithia-1,9,12,15,18,21,24,27,30-nonazabicyclo[30.3.0]pentatriacontane-8-carboxylic acid 1000000 NA NA NA NA NA TTD
ST14 (3R,8R,11S,14S,17S,20S,23S,26S,29S,32S)-3-amino-20-[(1-carbamimidoylpiperidin-4-yl)methyl]-11-(carboxymethyl)-23-(hydroxymethyl)-17,26-bis[(4-hydroxyphenyl)methyl]-29-methyl-14-(2-methylpropyl)-2,10,13,16,19,22,25,28,31-nonaoxo-5,6-dithia-1,9,12,15,18,21,24,27,30-nonazabicyclo[30.3.0]pentatriacontane-8-carboxylic acid 1000000 NA NA NA NA NA TTD
ST14 cyclo[Arg-Cys(1)-Tyr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro-Asp-Gly] 480000 NA NA NA NA NA BindingDB|TTD
ST14 (Z)-2-cyano-3-(4-hydroxy-3-methoxyphenyl)-N-(4-methoxyphenyl)prop-2-enamide NA 120000 NA NA NA NA BindingDB|TTD
ST14 (5E)-5-[(3,4-Dimethoxyphenyl)methylidene]-3-{[(5-fluoro-2-methylphenyl)amino]methyl}-1,3-thiazolidine-2,4-dione NA 103000 NA NA NA NA BindingDB|TTD
ST14 Benzamidine 400000 NA NA NA NA NA BindingDB|TTD
ST14 cyclo[Arg-Ser-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Ser-Phe-Pro-Asp-Gly] 107000 NA NA NA NA NA BindingDB
ST14 cyclo[Arg-Cys(1)-Thr-Orn-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-D-Pro-Asp-Gly] 250000 NA NA NA NA NA TTD
ST14 cyclo[Arg-Ser-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Ser-Phe-D-Pro-Asp-Gly] 107000 NA NA NA NA NA TTD
ST14 3-Amino-N-(3-{(S)-1-[4-(2-amino-ethyl)-piperidine-1-carbonyl]-3-phenyl-propylsulfamoyl}-phenyl)-propionamide 1000000 NA NA NA NA NA TTD
ST14 3-Amino-N-(3-{(S)-1-[4-(2-amino-ethyl)-piperidine-1-carbonyl]-4-phenyl-butylsulfamoyl}-phenyl)-propionamide 1000000 NA NA NA NA NA TTD
ST14 (E)-3-[3-[(4-chlorophenoxy)methyl]-4-methoxyphenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one NA 138000 NA NA NA NA BindingDB|TTD
ST14 (Z)-2-(1H-benzimidazol-2-yl)-3-[3-methoxy-4-(2-morpholin-4-yl-2-oxoethoxy)phenyl]prop-2-enenitrile NA 128000 NA NA NA NA BindingDB|TTD
ST14 (Z)-2-cyano-3-(4-hydroxy-3-methoxyphenyl)-N-(4-hydroxyphenyl)prop-2-enamide NA 111000 NA NA NA NA BindingDB|TTD
STAT1 4-[(2S)-2-[(4-cyanophenyl)formamido]-2-{[(1S)-1-[(3-methoxyphenyl)carbamoyl]-3-methylbutyl]carbamoyl}ethyl]phenoxyphosphonic acid NA 560000 NA NA NA NA TTD
STAT1 4-[(2S)-2-[(4-cyanophenyl)formamido]-2-{[(1S)-1-[(3-hydroxypropyl)carbamoyl]-3-methylbutyl]carbamoyl}ethyl]phenoxyphosphonic acid NA 620000|210000 NA NA NA NA BindingDB|TTD
STAT1 4-[(2S)-2-[(4-cyanophenyl)formamido]-2-{[(1S)-1-(cyclohexylcarbamoyl)-3-methylbutyl]carbamoyl}ethyl]phenoxyphosphonic acid NA 605000 NA NA NA NA TTD